South Delhi Pharma Delhi

Bortenat is used in medication of a cancer chemotherapy drug used to treat certain types of tumors like multiple myeloma, mantle cell lymphoma. It blocks certain proteins which helps to slow the growth and spread of the cancer.

Gemcite is used in various carcinomas: Non-small cell lung cancer, pancreatic cancer, bladder cancer and breastcancer. It is also being studied in the treatment of other types of cancer. Gemcite blocks the cell from making DNA and may kill cancer cells. It is a type of antimetabolite.

ABRAXANE for Injectable Suspension (paclitaxel protein-bound particles for injectable suspension) is indicated for the treatment of breast cancer after failure of combination chemotherapy for metastatic disease or relapse within 6 months of adjuvant chemotherapy. Prior therapy should have included an anthracycline unless clinically contraindicated.

Veenat is used in treating chronic myelogenous leukemia (CML), gastrointestinal stromal tumors (GISTs), leukemias and other cancers. Cancers are characterized by uncontrolled growth of cells, and leukemia is a specific type of cancer characterized by uncontrolled proliferation of white blood cells

We are offering geftinat. Geftinat gefitinib 250 mg tablets as monotherapy treatment for patients with locally advanced or metastatic non-small cell lung cancer (nsclc) after failure of both platinum-based and docetaxel chemotherapies. Gefitinib is not recommended for use in combination with chemotherapy.

LUCENTIS® (ranibizumab injection) is a recombinant humanized IgG1 kappa isotype monoclonal antibody fragment designed for intraocular use. Ranibizumab binds to and inhibits the biologic activity of human vascular endothelial growth factor A (VEGF-A). Ranibizumab, which lacks an Fc region, has a molecular weight of approximately 48 kilodaltons and is produced by an E. coli expression system in a nutrient medium containing the antibiotic tetracycline. Tetracycline is not detectable in the final product.